Detalles de la búsqueda
1.
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.
Br J Cancer
; 118(2): 162-170, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29182608
2.
Improved survival with bevacizumab in advanced cervical cancer.
N Engl J Med
; 370(8): 734-43, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24552320
3.
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Lancet Oncol
; 16(3): 301-11, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25638326
4.
Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.
Int J Gynecol Cancer
; 25(2): 303-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25405577
5.
Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
Gynecol Oncol
; 129(3): 478-85, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23535279
6.
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(2): 315-9, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22307062
7.
Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature.
J Obstet Gynaecol Res
; 38(1): 340-4, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22136798
8.
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 116(1): 44-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19853287
9.
Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.
Gynecol Oncol
; 117(2): 248-54, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20189232
10.
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
Gynecol Oncol
; 112(3): 543-52, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19108877
11.
Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies.
Am J Obstet Gynecol
; 199(5): 539.e1-6, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18565487
12.
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors.
Clin Cancer Res
; 24(4): 744-752, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29138343
13.
Prevention, diagnosis, and treatment of cervical cancer.
Mayo Clin Proc
; 82(12): 1566-74, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18053467
14.
Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.
J Clin Oncol
; 23(21): 4617-25, 2005 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15911864
15.
Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183.
J Clin Oncol
; 23(30): 7454-9, 2005 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16234512
16.
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
J Clin Oncol
; 23(21): 4626-33, 2005 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15911865
17.
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
J Clin Oncol
; 23(36): 9329-37, 2005 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16361632
18.
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
J Clin Oncol
; 21(15): 2849-55, 2003 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12885800
19.
Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.
J Clin Oncol
; 21(15): 2843-8, 2003 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12807937
20.
Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
J Clin Oncol
; 21(23): 4350-5, 2003 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14645424